Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Filings indexed 1,484 across all filing types
Latest filing 2023-03-20 Earnings Release
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Sales revenues for February 2023
Earnings Release Classification · 100% confidence The document is very short (449 characters) and provides a brief update on sales performance for February 2023 and the first two months of 2023, labeled as a 'Current report №17/ 2023'. This format, focusing on key performance indicators (KPIs) without the comprehensive detail of a full financial statement (like 10-K or IR), strongly suggests an initial, high-level announcement of periodic results. This aligns best with the Earnings Release (ER) definition, which covers initial announcements of periodical financial results (key highlights only). It is not a full report, nor is it a general regulatory filing (RNS) since it fits the ER category. Q1 2023
2023-03-20 English
Consolidated financial report according to IFRS as at 31 December 2022
Regulatory Filings Classification · 19% confidence
2023-03-01 Polish
Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 17 February 2023.
Director's Dealing Classification · 100% confidence The document explicitly states it is a 'NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014'. It details transactions executed by an entity ('Telso' AD) related to an individual ('Vesela Stoeva') concerning shares in the Company. This directly corresponds to the definition of Director's Dealing (insider trades by executives/directors). The filing type code for this is DIRS.
2023-02-21 English
Notification for share participation from "Telso" AD
Major Shareholding Notification Classification · 99% confidence The document is a 'Current report' dated February 21, 2023, notifying that a shareholder ('Telso' AD) has reduced its stake below the 5% threshold following a tender offer. This action directly relates to a change in significant share ownership levels. This aligns perfectly with the definition of Major Shareholding Notification (MRQ). The document is very short, but its content is a specific notification about shareholding changes, not just an announcement that a report is available.
2023-02-21 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 20 February 2023.
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions executed by an entity related to a director/insider ("Ognian Donev") involving the company's shares. This directly corresponds to the definition of Director's Dealing (insider trades). The appropriate code is DIRS.
2023-02-21 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 17 February 2023.
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions (Buy) executed by an entity related to a key person ("Donev Investments Holding" AD related to Ognian Donev) involving the company's shares. This directly corresponds to the definition of Director's Dealing (insider trades). Matching Definition: 9. Director's Dealing (Code: DIRS): Report of personal share transactions by company directors and executives (insider trades).
2023-02-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.